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Strain preservationThe present study was performed to develop a suitable cryoprotectant solution for cryopreservation of rat
two-cell stage embryos. First, we examined the cell permeability of several cryoprotectants; propylene
glycol had the fastest permeability compared to dimethyl sulfoxide, ethylene glycol, and glycerol. Embryos
were then exposed to a solution containing propylene glycol to evaluate its effects on fetal development.
As the development was similar to that of fresh embryos, P10 (10% v/v propylene glycol in PB1) was used
as a pretreatment solution. Next, the effects of the vitriﬁcation solution components (sucrose, propylene
glycol, ethylene glycol, and Percoll) were examined by observing the vitriﬁcation status; 10% v/v propyl-
ene glycol, 30% v/v ethylene glycol, 0.3 mol sucrose, and 20% v/v Percoll in PB1 (PEPeS) was the minimum
essential concentration for effective vitriﬁcation without the formation of ice crystals or freeze fractures.
A new vitriﬁcation method using P10 and PEPeS was tested using rat embryos. The survival rate of vit-
riﬁed embryos after exposure to P10 for 120, 300, or 600 s ranged from 95.9% to 98.3%. The fetal develop-
mental rate ranged from 57.7% to 65.2%, which was not signiﬁcantly different from that of fresh embryos.
The experimental results indicated that vitriﬁcation using a combination of P10 and PEPeSwas suitable for
cryopreservation of rat early stage embryos.
 2014 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license. Introduction
Rats are used for studies in various ﬁelds, including behavioral
science, biochemistry, neurobiology, physiology, and pharmacol-
ogy [7]. Therefore, many strains suitable for various types of
studies, such as inbred, congenic, and recombinant inbred strains,
have been developed. In addition, recent advances in genetic
modiﬁcation technology have resulted in the production of many
transgenic rat strains [20] and knock-out strains using zinc-ﬁnger
nuclease [4] or embryonic stem cells [22]. Moreover, back-crossing
of genetically modiﬁed rats may be conducted with rats in other
genetic backgrounds and new strains with multiple modiﬁed genes
may be produced by intercrossing genetically modiﬁed strains [1].
Very large breeding spaces are required to maintain rat strains at
the individual level, and the need for space will continue to grow.On the other hand, the development of mouse embryo banks in
which the strains are cryopreserved at the embryo level have
shown great promise. These embryo banks have prevented the dis-
continuation of strains due to genetic mutation or natural disasters
and provide a signiﬁcant cost-savings, including avoiding the need
for breeding space [11]. As the cost to maintain rat strains are even
higher than that for mice, it is important to preserve rat strains by
cryopreserving early-stage embryos. We planned to build a rat em-
bryo bank by cryopreserving early rat embryos.
Whittingham [24] modiﬁed the slow freezing method used for
mouse early-stage embryos and cryopreserved two-, four-, and
eight-cell stage rat embryos. In addition, Kono [12], Isachenko
[6], Tada [19], Jiang [8], Anzai [2], and Seita [17] cryopreserved
rat embryos using the vitriﬁcation method. Thus, methods used
successfully for other animal species have been applied to rats,
usually with some modiﬁcation. In the present study, we deter-
mined the optimal pre-treatment for vitriﬁcation and the compo-
nents of the vitriﬁcation solution using rat two-cell embryos. To
facilitate manipulation of the collection and embryo transfer,
two-cell stage embryos are used for cryopreservation in many
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vation of rat embryos using the two-cell stage embryos.
Han et al. Han et al. [5] reported that embryo survival and in vivo
development are improvedwhen two-cell stage rat embryos are ex-
posed to a pretreatment solution containing a low concentration of
cell-permeable cryoprotectant, and vitriﬁcation of these embryos
is then conducted. Based on these ﬁndings, we investigated the vit-
riﬁcation method after pretreatment of two-cell stage rat embryos.
For pretreatment, as it is necessary to select a cryoprotectant with
low cytotoxicity and with a low risk of damaging the embryos due
to osmotic expansion, we investigated the permeation rate of cell-
permeable cryoprotectants and fetal development. To prevent dam-
age to the embryos by osmotic expansion afterwarmingwithout the
occurrence of freeze fractures when the vitriﬁcation solution vitri-
ﬁes after cooling,we investigateddifferent types and concentrations
of cell-permeable cryoprotectants, sugars, and high molecular
weight molecules added to the vitriﬁcation solution. Using the pre-
treatment and vitriﬁcation solutions developed in this study, vitriﬁ-
cation of rat two-cell stage embryoswas conducted and the survival
and in vivo development after warming were investigated.Materials and methods
Animals
Rats of the BrlHan:WIST@Jcl(GALAS) strain (CLEA Japan, Inc.,
Tokyo Japan) were used for the experiments. The breeding condi-
tions were as follows: room temperature, 22 ± 0.5 C; humidity,
55 ± 5%; and lighting from 08:00 to 20:00. Rat chow (CA-1; CLEA
Japan Inc.) and tap water were available ad libitum. The breeding
and animal experiments using these rats were carried out in accor-
dance with rules of the Central Institute for Experimental Animals
after approval by the Committee of Animal Experiments.
Collection of two-cell stage embryos and in vivo development
PB1 medium [23] was used to collect two-cell stage embryos
and embryo transfer. All reagents for preparing PB1 were pur-
chased from Sigma Chemical Co. (St. Louis, MO). For embryo collec-
tion, 150 IU/kg of equine chorionic gonadotropin (Serotropin;
ASUKA Pharmaceutical Co., Ltd., Tokyo, Japan) and 75 IU/kg of hu-
man chorionic gonadotropin (Gonatropin; ASUKA Pharmaceutical
Co., Ltd.) were administered intraperitoneally to female rats at an
interval of 48 h (administration time: 12:00–14:00) to induce
superovulation [18]. Immediately after administration of human
chorionic gonadotropin, female rats were bred with male rats of
the same strain, and euthanized 1.5 d post coitum (dpc). The ovar-
ian ducts were perfused and the embryos were collected. To exam-
ine the in vivo development, embryo transfer was performed into
the ovarian ducts of pseudopregnant female rats on 0.5 dpc.
On day 18.5–19.5 after embryo transfer, the pseudopregnant
female rats were deeply anesthetized and laparotomy was per-
formed to observe implantation and fetal development.
Cell permeability and cytotoxicity of cryoprotectant
Although the embryos exposed to cryoprotectant solution (CPS)
shrunk, when the cell-permeable cryoprotectant added to the CPS
penetrated the cell, with time the volume of the cell recovered.
Therefore, the permeation speed of cryoprotectant into the cells
can be determined by measuring the cell volume at speciﬁc time
intervals after exposure of the cells to CPS. We adjusted the CPS
(v/v) and measured the cell volume using the method of Pedro
et al. Pedro et al. [16]. In the experiment, we used CPS (CPS20) to
which we added 20% v/v cell-permeable cryoprotectant in PB1.All cell-permeable cryoprotectants were purchased from Sigma
Chemical Co. Brieﬂy, the 2-cell stage embryos were exposed to
CPS20 at 25 ± 0.5 C and the cell diameter was measured 0
(control), 30, 60, 120, 180, 240, and 300 s later. The volume was
calculated with the formula V = S3/2 (S: relative cross-sectional
area; V: relative volume, S = pab; a: radius of the long axis; b: ra-
dius of the minor axis) and the ratio of the volume at each time
point was calculated with the control volume.
To investigate the cytotoxicity, CPS (CPS10) containing the cryo-
protectant with the fastest cell permeability at a concentration of
10% v/v in PB1 was used. After the embryos were exposed to
CPS10 for 300 or 600 s at 25 ± 0.5 C, they were shifted to a solution
containing 0.3 mol sucrose in PB1 (SPB1), and then left at rest for
120 s. The embryos were then washed with PB1 three times and
embryo survival was conﬁrmed. The surviving embryos after expo-
sure to CPS were examined for in vivo development.
Cryoprotectant added to vitriﬁcation solution
First, we prepared ﬁve types of CPS containing 0.3 mol sucrose,
10% v/v propylene glycol, and various amounts of ethylene glycol
(10%, 15%, 20%, 25%, or 30% v/v) in PB1 (Table 3). Then, 100 ll of
each of these solutions was placed into cryotubes (MS-4501W;
Sumitomo Bakelite Co. Ltd., Tokyo, Japan) and the cryotubes were
cooled for 30 min in liquid nitrogen. The cooled solution was con-
sidered to be vitriﬁed if it became transparent. Cracks in the cooled
solution indicated the presence of freeze fractures. We then
prepared three types of CPS containing Percoll (GE Healthcare,
Sweden) at concentrations of 10%, 15%, or 20% v/v, and then eval-
uated the ability of each solution to vitrify and whether freeze frac-
tures were present. The type and concentration of cryoprotectant
added to the vitriﬁcation solution was determined based on the
performance of the 8 types of CPS described above. Furthermore,
we evaluated the vitriﬁcation using the vitriﬁcation solution. First,
5 ll of pretreatment solution was placed into the cryotubes and
cooled to 0 C for 60 s. Then, 95 ll of precooled (0 C) vitriﬁcation
solution was added to the cryotubes, and 60 s later the cryotubes
were placed in liquid nitrogen. The solution was observed after
cooling for 30 min. The cooled solution was considered to be vitri-
ﬁed if it became transparent. Cracks in the cooled solution indi-
cated the presence of freeze fractures.
Vitriﬁcation and warming of two-cell stage embryos
First, the two-cell stage embryos were exposed to the pretreat-
ment solution at 25 ± 0.5 C for 120, 300, and 600 s. The embryos
and 5 ll of pretreatment solution was then placed into the cryotu-
bes and cooled to 0 C for 60 s. We then added 95 ll of precooled
(0 C) vitriﬁcation solution to the cryotubes, and 60 s later the
cryotubes were placed in liquid nitrogen for vitriﬁcation. In a group
that was vitriﬁed without pretreatment, the embryos and 5 ll of
PB1 were placed into cryotubes, and then vitriﬁcation was per-
formed using the same procedures. The vitriﬁed embryos were
stored in liquid nitrogen for at least 7 days.
To warm the embryos, the cryotubes were shifted from liquid
nitrogen to 25 ± 0.5 C, and 30 s later, 900 ll of SPB1 at 37 C was
added. The warmed embryos were placed in PB1 120 s after the
addition of SPB1, left at rest for 120 s, washed with PB1 three
times, and embryo survival was conﬁrmed. The surviving embryos
after warming were examined for in vivo development.
Statistical analysis
The experimental results of the change in cell volume, survival,
and development of two-cell stage embryos are expressed as
means ± standard error of means (SEM). Statistical analysis was
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data, Statcel2 (The Publisher OMS Ltd., Saitama, Japan), automated
analysis software, was used. In all analyses, P < 0.01 was taken to
indicate statistical signiﬁcance.Results
Types and concentrations of pretreatment solution and cryoprotectant
added to vitriﬁcation solution
The cell volume ratio after exposure of the two-cell stage em-
bryos to CPS20 became the lowest after 30 s in propylene glycol
(0.70), dimethyl sulfoxide (0.55), and ethylene glycol (0.52), and
after 60 s in glycerol (0.49; Fig. 1, Table 1). After 240 s, the cell vol-
ume ratio in propylene glycol recovered to 0.90, that in dimethyl
sulfoxide recovered to 0.76, that in ethylene glycol recovered toTable 1
Standard error of means (SEM) of the relative volume for two-cell embryo after
exposure to cryoprotectants from 30 to 300 s.
Exposure
time (s)
Cryoprotectant
Propylene
glycol
Ethylene
glycol
Dimethyl
sulfoxide
Glycerol
30 0.022 0.024 0.016 0.021
60 0.026 0.024 0.014 0.019
120 0.022 0.026 0.013 0.020
180 0.022 0.023 0.014 0.021
240 0.019 0.022 0.017 0.024
300 0.019 0.022 0.014 0.026
Table 2
Embryo survival and in vivo development after exposure to cell-permeable cryoprotectan
Treatment Exposure
time (s)
No. of embryos
survived/exposed (%)*
In vivo
No. of i
(% ± SEM
Untreated (control) – – 63/80 (
Treated with P10 300 84/84 (100) 66/84 (
Treated with P10 600 80/80 (100) 72/80 (
* There were no signiﬁcant differences among any groups (P > 0.01).
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Fig. 1. Volume change of cells after cell-permeable cryoprotectant exposure. Rat
two-cell stage embryos were exposed to four types of 20% v/v cell-permeable
cryoprotectants (PG, DMSO, EG, Gly) in PB1 at 25 C for 5 min. The diameters of 18–
26 cells (PG, n = 26; DMSO, n = 18; EG, n = 18; Gly, n = 18) were measured.0.73, and that in glycerol recovered to 0.58. Even after 300 s, the
cell volume ratio was 0.80 in dimethyl sulfoxide, 0.75 in ethylene
glycol, and 0.60 in glycerol, none of which exceeded 0.9. Further-
more, we attempted to calculate the volume change of the cells
in response to changes in the molar concentration of the cryopro-
tectant. The amount of each cryoprotectant was: propylene glycol
2.6 mol, dimethyl sulfoxide 2.6 mol, ethylene glycol 3.2 mol, and
glycerol 2.2 mol. We calculated the ratio of the molar concentra-
tion of each solution relative to that of propylene glycol (equation:
Ratio of the molar concentration of each cryoprotectant = Molar
concentration of each cryoprotectant/Molar concentration of pro-
pylene glycol). Next, we calculated the expected volume of the
cells based on the ratio of molar concentrations (equation: Volume
of cells based on the molar concentration ratio of the cryoprotec-
tant = Volume of the cell  Ratio of the molar concentration of each
cryoprotectant). The change in volume of the cells based on the cal-
culations was plotted as shown in Fig. 1, as measured by percent
concentration (v/v). The results of the experiment in which em-
bryos were exposed to CPS20 indicated that propylene glycol was
the cryoprotectant with the fastest permeability into rat two-cell
stage embryos.
We then investigated the cytotoxicity of propylene glycol. All of
the embryos exposed to CPS10 for 300 or 600 s survived (Table 2).
The fetus development rate was 73.8% for the fresh embryos (con-
trol), 72.6% for those exposed to CPS10 for 300 s, and 82.5% for
those exposed to CPS10 for 600 s. Implantation rate and fetus
development were not signiﬁcantly different among the groups.
Based on the results of the vitriﬁcation experiment, CPS10 (hereaf-
ter referred to as P10) was used as the pretreatment solution and
the exposure time was set to a maximum of 10 min at 25 ± 0.5 C.
When CPS containing a mixture of sucrose and cell-permeable
cryoprotectant was cooled in liquid nitrogen, the color of the solu-
tion was milky white in CPS-A and CPS-B and semitransparent in
CPS-C and CPS-D (Table 3). CPS-E vitriﬁed (transparent) but con-
tained freeze fractures. Percoll was then added to CPS-E and the
mixture was cooled in liquid nitrogen. CPS-F and CPS-G produced
freeze fractures, but CPS-H did not. In addition, the P10 was ﬁrst
placed in a cryotube and cooled with liquid nitrogen with the addi-
tion of CPS-H. The solution was vitriﬁed and contained no freeze
fractures. Based on the experimental results, CPS-H (10% v/v pro-
pylene glycol, 30% v/v ethylene glycol, 0.3 mol sucrose, and 20%
v/v Percoll; PEPeS) was added to the vitriﬁcation solution as the
cryoprotectant for the embryo vitriﬁcation experiments.Survival and in vivo development of vitriﬁed two-cell stage embryos
The survival rates of vitriﬁed two-cell stage embryos after pre-
treatment were 95.9%, 98.3%, and 95.9% for those pretreated for
120, 300, and 600 s, respectively; these differences were not signif-
icant (Table 4). The survival rate of vitriﬁed embryos without pre-
treatment, however, was 63.9%, which was signiﬁcantly lower than
those of the pretreated embryos. The fetus development rate was
73.0% for the fresh embryos (control), and 57.7%, 65.2%, and
59.5% for those pretreated for 120, 300, and 600 s, respectively (Ta-ts.
development of embryos after exposure Frequency of
experiment
mplantation/transferred
)*
No. of fetuses/transferred
(% ± SEM)*
78.8 ± 4.8) 59/80 (73.8 ± 5.0) 8
78.6 ± 8.5) 61/80 (72.6 ± 8.7) 9
90.0 ± 2.7) 66/80 (82.5 ± 3.7) 8
Table 4
Survival and in vivo development of embryos after vitriﬁcation.
Pre-treatment Exposure time
of pre-treatment
solution (s)
Survival of embryos after vitriﬁcation In vivo development of embryos after vitriﬁcation
No. of embryos
recoverd/
vitriﬁed (% ± SEM)*
No. of embryos
survived/
recoverd (% ± SEM)**
Frequency of
experiment
No. of implantation/
transferred
(% ± SEM) **
No. of fetuses/
transferred
(% ± SEM) **
Frequency of
experiment
Fresh embryos
(Control)
– – – – 81/100 (81.0 ± 4.3)a 73/100 (73.0 ± 4.2)a 10
Treated with P10 120 121/123 (98.4 ± 1.1) 116/121 (95.9 ± 2.2)a 12 65/104 (62.5 ± 5.5)a 60/104 (57.7 ± 5.8)a 11
Treated with P10 300 117/125 (93.6 ± 4.3) 115/117 (98.3 ± 4.3)a 13 88/115 (76.5 ± 4.5)a 75/115 (65.2 ± 5.3)a 13
Treated with P10 600 121/125 (96.8 ± 1.6) 116/121 (95.9 ± 1.7)a 13 90/116 (77.6 ± 3.6)a 69/116 (59.5 ± 5.2)a 13
Without
pre-treatment
0 119/120 (99.2 ± 0.8) 76/119 (63.9 ± 2.1)b 6 0/76 (0.0 ± 0.0)b 0/76 (0.0 ± 0.0)b 6
* There were no signiﬁcant differences among any groups (P > 0.01).
** Values within a column with no common superscripts are signiﬁcantly different (P > 0.01).
Table 3
Components of vitriﬁcation solution and conditions after cooling in liquid nitrogen.
Group Composition of cryoprotectant State of the solution after cooling in liquid nitrogen
Small saccharide
(mol)
Permeating (%, v/v) Macromolecule (%, v/v) Type of the solution
after cooling
Formation of
freeze fracturing
Sucrose Propylene
glycol
Ethylene
glycol
Percoll
CPS-A 0.3 10 10 – Milky Unformed
CPS-B 0.3 10 15 – Milky, partially semitransparent Unformed
CPS-C 0.3 10 20 – Semitransparent Unformed
CPS-D 0.3 10 25 – Semitransparent Formed
CPS-E 0.3 10 30 – Transparent Formed
CPS-F 0.3 10 30 10 Transparent Formed
CPS-G 0.3 10 30 15 Transparent Formed
CPS-H (PEPeS) 0.3 10 30 20 Transparent Unformed
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signiﬁcantly different between these groups. The implantation rate
and fetus development rate in the group without pretreatment,
however, were both 0%.Discussion
The CPS used for vitriﬁcation must prevent damage due to ice
crystal formation and growth, osmotic damage, and damage due
to freeze fractures after the cytotoxicity of the cryoprotectant is
suppressed [9]. P10 was expected to inhibit intracellular ice crystal
formation and growth. If the cryoprotectant permeates the embryo
too slowly, however, the amount of cryoprotectant required to pre-
vent ice crystal formation and growth may not enter the cells. It is
also assumed that water rapidly penetrates from outside of the
cells immediately after warming, before diffusion of intracellular
cryoprotectant can occur, and the cells may be damaged due to os-
motic expansion [15]. Moreover, if the time that the embryo is ex-
posed to the pretreatment solution is too long, then cytotoxicity
can occur [14]. In the experiments to develop the pretreatment
solution for rat two-cell stage embryos, propylene glycol was
selected because it had the fastest permeability (Fig. 1). Moreover,
as the fetus development rate in embryos exposed to P10 for
10 min was equivalent to that of controls (Table 2), it was consid-
ered that the amount of damage due to osmotic expansion and
cytotoxicity was extremely low.
PEPeS is a vitriﬁcation solution comprising a cell-permeable
cryoprotectant and non-cell-permeable cryoprotectant (sugar and
high molecular weight substance; Table 3). Because sucrose is
effective for preventing cell damage due to osmotic expansion
immediately after warming [3,10], 0.3 mol of sucrose was added
to make the PEPeS isotonic to the SPB1 that was used for warming.
A cell-permeable cryoprotectant was effective for vitriﬁcation ofCPS [9], therefore propylene glycol and ethylene glycol were also
added. The concentration of propylene glycol was ﬁxed as the same
concentration as that of the pretreatment solution to avoid cyto-
toxicity [14] and because a lower concentration of propylene glycol
would diffuse from the pretreated embryos to the CPS, which may
reduce freezing tolerance. Even at high concentrations, the cyto-
toxicity of ethylene glycol is low [14]. In addition, cell permeability
is lower for ethylene glycol than propylene glycol, and the toxic ef-
fects of ethylene glycol inside the cell are low (Fig. 1). Ethylene gly-
col was added to promote vitriﬁcation due to its low cytotoxicity.
Titterington et al. Titterington et al. [21] added 50% Percoll to vit-
riﬁcation solution (50% glycerol, 0.5 mol sucrose, 50% Percoll in
Ham’s F-10 medium). We found that the addition of 20% Percoll
to PEPeS prevented freeze fractures (Table 3).
No signiﬁcant differences in fetus development rate were
observed between the controls and embryos vitriﬁed with P10 pre-
treatment for 120, 300, or 600 s (Table 4). On the other hand, in the
method of Han et al. Han et al. [5], using 20% v/v ethylene glycol as
a pretreatment solution and 40% ethylene glycol as vitriﬁcation
solution, although the pretreatment time was 120 s and the expo-
sure time to the vitriﬁcation solution was the same as in the pres-
ent study, the in vivo development was signiﬁcantly lower than the
control. With regard to the permeability of cell-permeable cryo-
protectant into rat two-cell stage embryos, because the permeabil-
ity of propylene glycol was higher than that of ethylene glycol
(Fig. 1), use of a cryoprotectant with the fastest possible cell
permeability for pretreatment may improve intracellular freezing
tolerance. The survival rate of embryos vitriﬁed without P10 pre-
treatment was signiﬁcantly lower than in those with P10 pretreat-
ment (Table 4). Without the P10 pretreatment, no implantation or
fetus development was observed. In the experiments of Han et al.
Han et al. [5], manipulating the pretreatment solution did not
affect the embryo survival rate, but the in vivo development rate
was reduced without pretreatment. Han et al. Han et al. [5]
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permeability of the cell-permeable cryoprotectant. In our experi-
ments, permeation of the cryoprotectant was very low without
pre-treatment, intracellular ice crystals formed and grew, and the
in vivo development and survival of cryopreserved embryo might
be lower than that reported by Han et al Han et al. [5]. Although
PEPeS contains the same concentration of propylene glycol as
P10, one possible reason is that sufﬁcient amount of propylene gly-
col does not penetrate into the cells under conditions of 0 C and
60-s exposure. Moreover, 30% v/v ethylene glycol was also added
to PEPeS. Mukaida et al. Mukaida et al. [14] conducted vitriﬁcation
of mouse eight cell stage embryos using a vitriﬁcation solution to
which 30% v/v ethylene glycol was added and reported that when
the temperature at the time of exposure was decreased from 25 to
20 C, the survival rate of the embryos decreased from 95% to 51%.
In addition, when the exposure time was decreased from 120 to
30 s, the survival rate decreased to 0%. Thus, it is presumed that
ethylene glycol would have a similar tendency in our method.
In the present study, we attained completion of cryopreserva-
tion of rat two-cell stage embryos in which the cytotoxicity of
CPS was low and intracellular ice crystal formation and freeze frac-
tures at cooling was prevented along with osmotic injury immedi-
ately after warming. We believe that for preservation of rat strains,
use of two-cell stage embryos will be the most effective method
[13]. Further development of methods for cryopreservation of
two-cell stage embryos of other rat strains is still required. We
are currently using P10 and PEPeS to investigate vitriﬁcation of
the two-cell stage embryos of multiple strains.
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